WKB lawyers advised Orkla Group on the sale of its Polish skin care business, including the Soraya and Dermika brands, together with their Radzymin production facility, to Bielenda Kosmetyki Sp. z o.o. Sp.k.. Bielenda’s purchase of the Soraya and Dermika brands is part of a larger transaction whereby Innova Capital will acquire a majority stake in Bielenda. The preliminary enterprise purchase agreement was signed on 29 October 2020, and the sale, together with the Bielenda – Innova Capital transaction, is conditional on receiving antimonopoly approval from the Polish Office of Competition and Consumer Protection.
WKB provided Orkla Group with comprehensive legal support during the entire transaction process, including advising on the transaction’s structure, assisting during the due diligence and in the negotiation of the transaction’s terms and documentation.
Orkla ASA, a Norwegian company listed on the Oslo Stock Exchange, and Orkla Group are leading suppliers of branded consumer goods and concept solutions to the grocery sector, specialist retailers, out-of-home sectors and the bakery market. Its Polish subsidiary, Orkla Care S.A., is involved in the production and distribution of a wide range of cosmetics, and dietary, herbal, weight loss, and fitness supplement brands both in Poland and across Europe.
Bielenda Kosmetyki Sp. z o.o. Sp.k. is a Polish company engaged in the production and distribution of a wide range of natural cosmetics products for both consumer and professional use across Poland and world-wide.
Jakub Jędrzejak led the team’s work, whose key members were Ben Davey, Magdalena Piszewska , Dominik Kulpa and John Kedzierski , with support from Magdalena Zielińska-Kuć and Paulina Maślak-Stępnikowska from the firm’s intellectual property practice, Wioleta Polak and Magdalena Kurowicka from the firm’s employment law practice, Anna Wyrzykowska , Marta Czarnecka and Adrianna Kucharska from the firm’s real estate practice, and Wojciech Kulczyk from the firm’s competition and consumer law practice.